AAME ATLANTIC AMERICAN CORP
Price Chart
Executive Summary
Atlantic American Corp (AAME) received a Nasdaq delinquency notice on May 21, 2026 for failing to file its Q1 2026 10-Q and still being late on its FY2025 10-K, violating Listing Rule 5250(c)(1). The company has until June 16, 2026 to submit a compliance plan; if accepted, Nasdaq may grant until October 12, 2026 to file. This non-compliance event poses a material delisting risk for this $38M market cap life insurer, which would severely impact liquidity and institutional ownership.
Actionable Insight
The June 16, 2026 compliance plan submission deadline is the critical near-term catalyst. If Nasdaq rejects the plan or the company fails to file by October 12, 2026, delisting becomes highly probable. Traders should monitor for the compliance plan announcement and any updates on the delayed 10-K/10-Q filings. The historical T+20 performance on neutral reads for AAME has been poor (-16% avg); this bearish delisting notice may be a more material event that breaks that pattern.
Key Facts
- Nasdaq notice received May 21, 2026 for failure to file Q1 2026 10-Q and delinquent FY2025 10-K
- Violates Nasdaq Listing Rule 5250(c)(1) requiring timely filing of periodic financial reports
- Company has until June 16, 2026 to submit a plan to regain compliance
- If plan accepted, Nasdaq may grant up to 180 calendar days from Form 10-K due date (October 12, 2026) to regain compliance
- Notice has no immediate effect on listing or trading of AAME common stock on Nasdaq Global Market
Financial Impact
No specific financial figures provided; delisting would materially impair stock liquidity and access to capital markets for this $38M market cap issuer.
Risk Factors
- Delisting if compliance plan is rejected or filings are not completed by October 12, 2026
- Potential Nasdaq Hearings Panel appeal process if plan is rejected
- Continued filing delays could erode investor confidence and trigger further selling pressure
- No financial data disclosed in this filing — uncertainty about underlying business health
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-022626 |
| Document: ef20074674_ex99-1.htm | 0001140361-26-022626 |
| Document: 0001140361-26-022626-index-headers.html | 0001140361-26-022626 |
| Document: 0001140361-26-022626-index.html | 0001140361-26-022626 |
| Document: 0001140361-26-022626.txt | 0001140361-26-022626 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 22, 2026
15d ago
|
8-K
| $2.16 $2.03 | ▲ +6.02% | ▲ +7.23% | $1.67 (+22.69%) |
|
May 22, 2026
15d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 5, 2026
4w ago
|
8-K
| $2.51 $2.46 | ▼ −1.99% | ▼ −3.12% | $1.67 (−33.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access